These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11349271)

  • 41. Editorial response: De novo HBV infections after liver transplantation.
    Pruett TL
    Liver Transpl Surg; 1998 Mar; 4(2):182-4. PubMed ID: 9516574
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-HBs antibodies produced after liver transplantation: from the donor or the recipient?
    Maruyama T; Mitsui H; Hanajiri K; Sugawara Y; Imamura H; Makuuchi M
    Hepatology; 2003 Jul; 38(1):271-2; author reply 272. PubMed ID: 12830014
    [No Abstract]   [Full Text] [Related]  

  • 43. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F; Bunnapradist S; Martin P
    J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolated antibody to hepatitis B core antigen in individuals infected with HIV-1.
    Hung CC; Hsiao CF
    Clin Infect Dis; 2003 Nov; 37(9):1275-6;; author reply 1277. PubMed ID: 14557978
    [No Abstract]   [Full Text] [Related]  

  • 46. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can hepatitis B core antibody positive livers be used safely for transplantation: hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive.
    Van Thiel DH; De Maria N; Colantoni A; Friedlander L
    Transplantation; 1999 Aug; 68(4):519-22. PubMed ID: 10480410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination.
    Bárcena Marugán R; García-Hoz F; Vázquez Romero M; Nash R; Mateos M; González Alonso R; García González M; García Plaza A
    Am J Gastroenterol; 2002 Sep; 97(9):2398-401. PubMed ID: 12358263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver transplantation and de novo hepatitis B infection.
    Aldersley MA; Eglin RE; O'Grady JG
    Lancet; 1994 Mar; 343(8898):677. PubMed ID: 7906843
    [No Abstract]   [Full Text] [Related]  

  • 50. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.
    Chang SH; Suh KS; Yi NJ; Choi SH; Lee HJ; Seo JK; Lee KU
    Hepatology; 2003 Jun; 37(6):1329-34. PubMed ID: 12774011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle West region of Brazil.
    Aguiar JI; Aguiar E; Paniago A; Cunha R; Galvão L; Daher R
    Mem Inst Oswaldo Cruz; 2001 Feb; 96(2):185-7. PubMed ID: 11285495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
    Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
    Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B surface antigen is a better monitor of infectivity compared with antibody to hepatitis B core antigen in hemodialysis patients.
    Otani K; Kasuga Y; Kimura Y; Mukaide M; Yanai H; Koyama T; Fujise K
    Ther Apher Dial; 2010 Aug; 14(4):434-5. PubMed ID: 20649766
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B vaccination in heart transplant candidates.
    Foster WQ; Murphy A; Vega DJ; Smith AL; Hott BJ; Book WM
    J Heart Lung Transplant; 2006 Jan; 25(1):106-9. PubMed ID: 16399538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups.
    Koene RP; Gotz HM; Van Den Hoek JA; Heijnen ML; Van Steenbergen JA; Kroes AC
    Epidemiol Infect; 2009 Apr; 137(4):495-503. PubMed ID: 18647436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure.
    Güven R; Ozcebe H; Cakir B
    East Mediterr Health J; 2006 Nov; 12(6):749-57. PubMed ID: 17333819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.